Citation: | YANG Jinhua, YIN Minmin, ZHANG Jian, WANG Lei, YE Wencai, YIN Zhiqi. Simultaneous determination of seven C21steroidal saponins in the radix of Cynanchum otophyllum Schneid.by HPLC wavelength switching method[J]. Journal of China Pharmaceutical University, 2014, 45(2): 200-204. DOI: 10.11665/j.issn.1000-5048.20140212 |
[1] |
Jiang Y,Li BT.Flora of China(中国植物志)[M].Beijing:Science Press,1977:377.
|
[2] |
Sun YN,Yan JL.Clinical application of Cynanchum otophyllum Schneid.as a national medicine[J].Chin J Ethnomed Ethnopharm(中国民族民间医药杂志),1999,(5):309.
|
[3] |
Zhao XG,Tang LJ.Observation on the treatment of 20 cases of intractable epilepsy by Cynanchum otophyllum Schneid.[J].Shaanxi Med J(陕西新医药),1985,14(8):22-23.
|
[4] |
Xue SX,Yuan WC,Yang CM.Clinical analysis on the treatment of 20 cases of intractable epilepsy of children by Cynanchum otophyllum Schneid.[J].J Applied Clin Pediat(实用儿科临床杂志),1991,6(4):1931.
|
[5] |
Mu QZ,Shen YM,Zhou XL,et al.Extraction of novel otophyllosides C-G from Cynanchum otophyllum Schneid.for treatment of hepatitis and Meniere′s syndrome:CN,1150951[P].1997-07-04[2013-10-20] .
|
[6] |
Mu QZ,Shen YM,Zhou XL,et al.Two new antiepilepsy compounds otophlloside A and B:CN,1148958[P].1997-05-07[2013-10-20] .
|
[7] |
Peng YR,Ding YF,Wei YJ,et al.Caudatin-2,6-dideoxy-3-O-methy-β-D-cymaropyranoside induced apoptosis through caspase 3-dependent pathway in human heaptoma cell line SMMC-7721[J].Phytoth Res,2011,25(5):631-637.
|
[8] |
Li YB.Application of caudatin-3-O-β-D-cymarin in preparation of medicine for treating liver cancer:CN,101011404[P].2007-08-08[2013-10-20] .
|
[9] |
Peng YR,Li YB,Liu XD,et al.Antitumor activity of C21 steroidal glycosides from Cynanchum auriculatum Royle exWight[J].Phytomedicine,2008,15:1 016-1 020.
|
[10] |
Chen SY,Li LY,Chen Y,et al.Effect on lymphocyte in immunosuppressant mice of C21 steroid saponins in Cynanchum otophyllum Schneid.[J].Pharmacol Clin Chin Mater Med(中药药理与临床),1988,4(4):51-52.
|
[11] |
Sun SK,Tian SH,Li XP.Mechanism of Qingyangshen glycosides(QYS)treating on liver injury in mice[J].Ningxia Med J(宁夏医学杂志),2010,32(2):120-122.
|
[12] |
Ming QZ,Dong Y,Zhou XY.RP-HPLC assay for cynanchogenin in qingyangshen tablets[J].Chin J Pharm Anal(药物分析杂志),2006,26(8):1 156-1 157.
|
[13] |
Li WL,He WJ,Li HQ,et al.Determination of cynanchogenin in Cynanchum otophyllum Schneid.by HPLC[J].West China J Pharm Sci(华西药学杂志),2009,24(6):663-664.
|
[14] |
Mu QZ,Shen YM,Zhou XL,et al.Appication of otophylloside A and otophylloside B in pharmaceutical industry:CN,1148958[P].1997-05-07[2013-10-25] .
|
[15] |
Wu J,Ji L,Wang LF,et al.RP-HPLC with UV Switch determination of paeoniflorin and pepper alkali in Zhitong tablets[J].Chin J Exp Tradit Med Formulae(中国实验方剂学杂志),2011,19(15):140-142.
|
[16] |
Li WM, Zhao YR, Yang YY, et al. RP-HPLC with UV switch determination of 9 components in white peony root pieces[J].Chin J Pharm Anal(药物分析杂志),2011,31(12):2 208-2 012.
|
[1] | WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902 |
[2] | SUN Liting, ZHANG Weiguo, TONG Yue. Research progress on targeted protein S-palmitoylation modification in T cell immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(1): 45-52. DOI: 10.11665/j.issn.1000-5048.2023112903 |
[3] | CUI Zhenzhen, ZHAO Yifan, SUN Yu, Meng Jiayi, KANG Di, HU Lihong. Research progress of drugs for cancer immunotherapy based on CCL2/CCR2 signaling axis[J]. Journal of China Pharmaceutical University, 2024, 55(1): 36-44. DOI: 10.11665/j.issn.1000-5048.2023112904 |
[4] | YAO Zheng, LI Zihan, GAO Liming, HU Xing, CHEN Yan, PAN Wenqi, LI Qian. Advances of research on CAR-T cell immunotherapy for solid tumors[J]. Journal of China Pharmaceutical University, 2021, 52(4): 496-504. DOI: 10.11665/j.issn.1000-5048.20210413 |
[5] | YU Zexuan, JU Caoyun, ZHANG Can. Construction and application of gene delivery systems for primary dendritic cells[J]. Journal of China Pharmaceutical University, 2021, 52(4): 438-446. DOI: 10.11665/j.issn.1000-5048.20210406 |
[6] | XING Xuyang, WANG Xiaochun, HE Wei. Advances in research on tumor immunotherapy and its drug development[J]. Journal of China Pharmaceutical University, 2021, 52(1): 10-19. DOI: 10.11665/j.issn.1000-5048.20210102 |
[7] | JIANG Liangliang, JIANG Tao, LUO Jianhua, YAO Wenbing, TIAN Hong. A novel human immune system mice model for assessing the immunogenicity of cancer vaccines[J]. Journal of China Pharmaceutical University, 2019, 50(6): 734-742. DOI: 10.11665/j.issn.1000-5048.20190615 |
[8] | WANG Rui, WANG Yongmei, CAI Mingjun, KE Xuejia, WU Yue, CHONG Jun, CAO Rongyue. Pharmacological effects of anti-melanoma DC vaccine sensitized by fusion proteins of G3G6 and HST1[J]. Journal of China Pharmaceutical University, 2019, 50(2): 238-245. DOI: 10.11665/j.issn.1000-5048.20190216 |
[9] | ZHANG Rui, JIANG Tao, ZENG Tianzhu, YAO Wenbing, GAO Xiangdong, TIAN Hong. Advances of combined immunotherapy in tumor[J]. Journal of China Pharmaceutical University, 2018, 49(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20180401 |
[10] | JING Liangliang, MIAO Zitao, LI Manman, YE Jia, JIN Liang, CAO Rongyue, LONG Jun. Anti-tumor effect and its mechanism of co-administration of fusion proteins hVEGF121/βhCG and mGM-CSF/βhCG[J]. Journal of China Pharmaceutical University, 2017, 48(1): 102-109. DOI: 10.11665/j.issn.1000-5048.20170116 |